Europe
Qlucore Expands Into Bladder Cancer Diagnostics With Lund University Partnership
The company expects that this work to develop and validate classifier models for bladder cancer will lead to a CE mark for its Qlucore Diagnostics software platform.
Prostate Cancer UK Funds Study of Angle's Parsortix Liquid Biopsy Test in Prostate Cancer
The trial at Barts Cancer Institute will follow 200 prostate cancer patients over five years and gauge if the CTC test can identify who will recur after surgery.
Xilis Aims to Demonstrate Ability of Drug Screening Micro-Tumors to Personalize Cancer Therapy
Premium
The firm believes its micro-organosphere technology could guide treatment selection for more cancer patients than is currently possible with genomic testing.
BC Platforms, Euformatics, Oncompass to Develop Oncology NGS Workflows for European Hospitals
The companies have won a partially EU-funded contract from a coalition of seven hospitals to integrate, standardize, and analyze NGS data to inform clinical decision support.
Qiagen Gets CE Mark for Therascreen EGFR Plus RGQ Kit for Non-Small Cell Lung Cancer
The firm has launched the in vitro diagnostic test, which detects EGFR mutations in non-small cell lung cancer, in 11 countries that accept the CE mark.